LEXXNasdaqPharmaceutical PreparationsFiscal year ends August 31

Lexaria Bioscience Corp.

Financials through Q3 FY2026, quarter ended May 31, 2026Last filing: 10-Q on Jul 13, 2026

$2.60−0.26 (-9.09%)

Close on Oct 19, 2026

Market cap: $64.50M
P/E (TTM): –
Dividend yield: –

Lexaria Bioscience Corp. balance sheet

Annual Quarterly

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-08-31	FY 2024 2024-08-31	FY 2023 2023-08-31	FY 2022 2022-08-31	FY 2021 2021-08-31	FY 2020 2020-08-31	FY 2019 2019-08-31	FY 2018 2018-08-31	FY 2017 2017-08-31	FY 2016 2016-08-31	FY 2015 2015-08-31	FY 2013 2013-10-31	FY 2012 2012-10-31	FY 2011 2011-10-31	FY 2010 2010-10-31	FY 2009 2009-10-31
Cash & Equivalents	1.80	6.50	1.35	5.81	11	1.29	1.29	1.73	2.53	0.09	0.26	0.07	0.18	0.03	0.06	0.33
Short-Term Investments	0.14	0.06	0.13	0.35	0.83	0.02	0.06	0.01	0	–	–	–	–	–	–	–
Cash & Short-Term Investments	1.95	6.56	1.48	6.16	12	1.31	1.35	1.74	2.53	0.09	0.26	0.07	0.18	0.03	0.06	0.33
Receivables	0.37	0.15	0.13	0.20	0.34	0.31	0.27	0.27	0.05	0.13	0.03	0.08	0.29	0.23	0.07	–
Inventory	–	–	0	0.04	0.03	0.12	0.13	0.09	0.07	0.13	0.17	–	–	–	–	–
Prepaid Expenses & Other	1.13	1.19	0.55	0.58	0.32	0.18	0.07	0.19	0.15	0.15	0.22	0.00	0.00	0.00	0.00	–
Total Current Assets	3.47	7.90	2.15	6.98	12	1.93	1.82	2.28	2.80	0.51	0.67	0.15	0.47	0.26	0.14	–
Property, Plant & Equipment	0.23	0.25	0.25	0.32	0.37	0.48	0.59	0.00	0.00	0.00	0	–	0	0	0.00	–
Gross Property, Plant & Equipment	–	0.73	–	–	–	–	0.65	0.00	–	–	–	–	–	–	–	–
Accumulated Depreciation	–	-0.52	-0.48	-0.38	-0.28	-0.17	-0.06	0.00	–	–	–	–	–	–	–	–
Machinery & Equipment	–	0.73	0.70	0.65	0.65	0.65	0.65	0.00	–	–	–	–	–	–	–	–
Construction in Progress	–	–	–	–	–	–	–	0	–	–	–	–	–	–	–	–
Long-Term Investments	0.35	0.01	0.01	–	–	–	–	–	–	–	0	0	–	–	–	–
Operating Lease Right-of-Use Assets	0.11	0.17	0.17	–	0.09	0.13	0.16	–	–	–	–	–	–	–	–	–
Intangible Assets	0.31	0.52	0.46	–	–	0.29	0.27	0.15	0.06	0.05	–	–	–	–	–	–
Other Long-Term Assets	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.00	–
Total Assets	4.18	8.87	3.08	7.83	13	2.83	2.68	2.43	2.86	0.57	0.71	3.57	4.19	4.34	3.28	–
Accounts Payable	1.46	1.07	0.24	0.15	0.11	0.09	0.14	0.04	0.03	0.09	0.03	0.14	0.07	0.32	0.14	–
Current Portion of Leases	0.03	0.03	–	–	0.04	0.04	0	–	–	–	–	–	–	–	–	–
Deferred Revenue (Current)	0	0.00	–	0	–	–	0	0	0.02	0.01	0	–	–	–	–	–
Total Current Liabilities	1.49	1.10	0.27	0.19	0.15	0.23	0.18	0.04	0.09	0.43	0.06	1.42	1.71	1.08	1.05	–
Long-Term Leases	0.08	0.11	–	–	0.05	0.09	–	–	–	–	–	–	–	–	–	–
Operating Lease Liabilities	0.11	0.14	0.16	–	0.04	0.04	0.16	–	–	–	–	–	–	–	–	–
Total Liabilities	1.57	1.21	0.40	0.20	0.20	0.35	0.18	0.04	0.09	0.48	0.06	1.47	1.77	1.68	1.12	–
Common Stock	0.02	0.02	0.01	0.01	0.01	0.00	0.08	0.08	0.07	0.05	0.04	0.02	0.02	0.02	0.01	–
Additional Paid-In Capital	67	60	49	47	45	30	26	22	16	12	11	7.14	7.12	7.11	6.07	–
Retained Earnings	-63	-52	-46	-39	-32	-28	-24	-20	-13	-11	-10	-5.06	-4.71	-4.46	-3.92	–
Comprehensive Income & Other	-0.07	-0.02	0	–	–	–	–	-0.01	0	–	–	–	–	–	–	–
Shareholders' Equity	2.99	8.04	3.04	7.95	13	2.48	2.49	2.39	2.77	0.27	0.77	2.10	2.42	2.66	2.15	2.30
Noncontrolling Interest	-0.39	-0.38	-0.36	-0.32	-0.20	-0.04	0.11	–	-0.24	-0.18	-0.12	–	–	–	–	–
Total Equity	2.60	7.66	2.68	7.63	13	2.48	2.49	2.39	2.77	0.09	0.66	2.10	2.42	2.66	2.15	2.30
Total Liabilities & Equity	4.18	8.87	3.08	7.83	13	2.83	2.68	2.43	2.86	0.57	0.71	3.57	4.19	4.34	3.28	–
Shares Outstanding(shares)	20	20	8.09	5.95	5.73	3.00	2.63	2.52	2.27	1.71	1.46	0.55	0.55	0.55	0.43	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at May 31, 2026

Profitability, TTM

Gross margin: 100.0%
Operating margin: -3973.2%
Net margin: -3985.6%
Return on equity, FY2025: -215.9%

Financial strength

Current ratio: 10.60
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 912.9%

Valuation

P/E ratio: –
Price to sales: 332.45
Price to book: 13.61
Dividend yield: –